Literature DB >> 15025779

Occult hypoperfusion is associated with increased mortality in hemodynamically stable, high-risk, surgical patients.

André Meregalli1, Roselaine P Oliveira, Gilberto Friedman.   

Abstract

BACKGROUND: Our aim was to examine whether serial blood lactate levels could be used as predictors of outcome.
METHODS: We prospectively studied 44 high-risk, hemodynamically stable, surgical patients. Blood lactate values, mean arterial pressure, heart rate and urine output were obtained at patient admission to the study, at 12, 24 and 48 hours.
RESULTS: The nonsurvivors (n = 7) had similar blood lactate levels initially (3.1 +/- 2.3 mmol/l versus 2.2 +/- 1.0 mmol/l, P = not significant [NS]), but had higher levels after 12 hours (2.9 +/- 1.7 mmol/l versus 1.6 +/- 0.9 mmol/l, P = 0.012), after 24 hours (2.1 +/- 0.6 mmol/l versus 1.5 +/- 0.7 mmol/l, P = NS) and after 48 hours (2.7 +/- 1.8 mmol/l versus 1.9 +/- 1.4 mmol/l, P = NS) as compared with the survivors (n = 37). Arterial bicarbonate concentrations increased significantly in survivors and were higher than in nonsurvivors after 24 hours (22.9 +/- 5.2 mEq/l versus 16.7 +/- 3.9 mEq/l, P = 0.01) and after 48 hours (23.1 +/- 4.1 mEq/l versus 17.6 +/- 7.1 mEq/l, P = NS). The PaO2/FiO2 ratio was higher in survivors initially (334 +/- 121 mmHg versus 241 +/- 133 mmHg, P = 0.03) and remained elevated for 48 hours. There were no significant differences in mean arterial pressure, heart rate, and arterial blood oxygenation at any time between survivors and nonsurvivors. The intensive care unit stay (40 +/- 42 hours versus 142 +/- 143 hours, P < 0.001) and the hospital stay (12 +/- 11 days versus 24 +/- 17 days, P = 0.022) were longer for nonsurvivors than for survivors. The Simplified Acute Physiology Score II score was higher for nonsurvivors than for survivors (34 +/- 9 versus 25 +/- 14, P = NS). The urine output was slightly lower in the nonsurvivor group (P = NS). The areas under the receiving operating characteristic curves were larger for initial values of Simplified Acute Physiology Score II and blood lactate for predicting death.
CONCLUSION: Elevated blood lactate levels are associated with a higher mortality rate and postoperative complications in hemodynamically stable surgical patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15025779      PMCID: PMC420024          DOI: 10.1186/cc2423

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


Introduction

Acute hypoperfusion can be characterized by an imbalance between oxygen demand and oxygen delivery to the tissues. It has been proposed that organ damage in critical illness is due to inadequate oxygen delivery that fails to satisfy metabolic needs. Hypoperfusion is largely responsible for subsequent risk of multiple system organ failure. Experimentally and clinically, whenever the oxygen delivery is inadequate to maintain normal tissue oxygenation, blood lactate levels start to rise [1-6]. Blood lactate levels are closely related to outcome in critically ill patients [4,6-11]. We have also shown, like other workers, that failure of serum lactate levels to reach normal values within a specific time during critical illness could be even more closely related to survival than the initial level [6,11-14]. However, most studies have shown the prognostic value of blood lactate levels in patients with signs of clinical shock. Resuscitation of surgical patients has traditionally been guided by the normalization of vital signs, such as blood pressure, urine output, and heart rate; and only when hemodynamic instability invasive monitoring is required. However, these endpoints have revealed the inadequacy of relying solely upon vital signs in resuscitation of critically ill patients [15]. The ideal marker of adequate resuscitation should be able to assess resolution of hypoperfusion. There have been few studies to date evaluating the prognostic value of occult hypoperfusion, defined as elevated blood lactate levels without signs of clinical shock in critically ill patients [16]. Several studies by the same group of investigators in trauma patients have shown that persistent occult hypoperfusion is associated with increased morbi-mortality, and early correction seems to improve outcome [7,8,16]. Polonen and colleagues have shown in cardiac surgical patients that a goal-oriented protocol targeting a normal blood lactate can shorten the length of stay [17]. In addition, Rivers and colleagues have shown that interventions targeted on hemodynamic endpoints can decrease the mortality of severe septic patients with elevated blood lactate levels [18]. There has not previously been a study examining the prognostic value of blood lactate values on the outcome of high-risk, hemodynamically stable, surgical patients. We therefore conducted the present study to examine whether serial blood lactate levels could be used as predictors of outcome in this population.

Patients and methods

Patients

We prospectively studied 44 consecutive adult patients (30 male, 14 female) admitted to a general intensive care unit (ICU) after high-risk noncardiac surgery (Table 1). All high-risk surgical patients were admitted to the study if they showed two or more of the following inclusion criteria: major elective operation for removal of carcinoma that lasted at least 2 hours; elective repair of an abdominal aortic aneurysm; age > 70 years and evidence of limited physiologic reserve of one or more vital organs (creatinine > 2 mg/dl, cardiac ejection fraction < 50%); acute abdominal catastrophe (e.g. pancreatitis, peritonitis); and previous disease of a vital organ, defined as compensated or prior congestive cardiac failure, previous clinical indication of ischemic heart disease (previous myocardial infarction, ST–T depression during stress testing or Q-waves on electrocardiogram), cardiac arrhythmia with chronic use of antiarrhythmic drugs, chronic obstructive pulmonary disease as diagnosed by spirometric tests, or chronic liver disease Child B or Child C. The exclusion criteria were hemodynamic instability before or during surgery and during the first hour after admission to the ICU. Hemodynamic stability was defined as patients with no need for active resuscitation with fluids, pressors, or inotropes to keep urine output > 0.5 ml/kg per min, systolic arterial pressure > 90 mmHg, and heart rate < 120 beats/min.
Table 1

Demographics data

Survivors (n = 37)Nonsurvivors (n = 7)
Age (years)57 ± 1566 ± 13
Intensive care unit stay (hours)40 ± 42142 ± 143**
Surgery duration (min)323 ± 109294 ± 213
Hospital stay (days)12 ± 1124 ± 17*
Simplified Acute Physiology Score II25 ± 1434 ± 9
Inoperative blood loss (ml)440 ± 125580 ± 187
Surgical diagnosis
 Carcinoma of the esophagus92
 Peritonitis or abscess11
 Pancreatitis, infected pseudocyst, pancreatic abscess21
 Orthopedic spine surgery2
 Hepatic tumor2
 Carcinoma of the large bowel4
 Genitourinary surgery1
 Major vascular surgery5
 Carcinoma of the stomach, pancreas, bile duct102
 Other3
Clinical diagnosis
 Chronic obstructive pulmonary disease123
 Ischemic heart disease71
 Heart failure51
 Chronic liver disease62
 Chronic renal failure3
 Other4

Data presented as mean ± standard deviation or number of patients. *P < 0.05, **P < 0.01.

All patients were treated following the same protocol used in our ICU. No patients needed hemodynamic monitoring with a pulmonary artery catheter.

Measurements and study protocol

The ethics committee of our institution approved the study. The study was conducted at the Central ICU of the Santa Casa de Porto Alegre Hospital. Demographic data were collected by the ICU staff and included age, type of surgery, duration of surgery, hospital mortality, and risk of death for each patient predicted from the Simplified Acute Physiology Score II (SAPS II) [19]. Blood gas values were determined using a commercial blood-gas analyzer (Ciba-Corning, San Diego, CA, USA). Blood lactate concentrations were measured by an enzymatic technique (Cobas Mira Plus; Roche, Indianapolis, IN, USA). Blood lactate values, the mean arterial pressure, the heart rate and the urine output were obtained at patient's admission to the study, at 12, 24 and 48 hours. Blood arterial gases were obtained daily. SAPS II was recorded at admission. Other values recorded included demographic data, serum chemistries, surgery and ICU or hospital stay duration, and hospital mortality.

Statistical analysis

An unpaired Student t test was used to compare differences between groups at study admission. Changes over time were analyzed using a two-way analysis of variance for repeated measurements. Newman–Keuls' test was used for post-hoc comparisons. We determined the accuracies of the study variables by constructing their receiver operating characteristics curves. Statistical significance was accepted to correspond to P < 0.05. All data are presented as means ± standard deviation.

Results

Clinical data for the 44 patients are summarized in Table 1. Twenty-nine survivors were discharged before 48 hours of ICU stay. Five patients died during the ICU stay, four of them dying from septic shock. Another two patients died after discharge from the ICU. Figure 1 shows the changes in arterial lactate and bicarbonate. The survivors' blood lactate levels decreased significantly with time, but levels remained stable in the nonsurvivor group. A significant difference for lactate concentrations was seen after 12 hours. Arterial bicarbonate levels increased significantly in survivors and were higher than in nonsurvivors up to 48 hours. No correlation was found between lactate and bicarbonate or base excess at any time.
Figure 1

Time course of (a) blood lactate and (b) arterial bicarbonate concentrations in survivors (●) and in nonsurvivors (▽). Values are mean ± standard deviation. *Significant (P < 0.05) differences between the two groups at 24 hours. **Significant (P < 0.05) differences versus baseline.

The ICU stay and the hospital stay were longer for nonsurvivors. SAPS II was higher for nonsurvivors than for survivors (P = not significant). The PaO2/FiO2 ratio and the urine output tended to be lower, and the heart rate tended to be higher in nonsurvivors during time (Table 2). There were no significant differences in age or serum albumin at admission. The values for mean arterial pressure and arterial blood oxygenation parameters were statistically similar for survivors and nonsurvivors at any time.
Table 2

Vital signs and oxygenation variables in the survivors and nonsurvivors

VariableGroupAdmission12 hours24 hours48 hours
Mean arterial pressure (mmHg)Survivors99 ± 2583 ± 2085 ± 1591 ± 15
Nonsurvivors90 ± 676 ± 1187 ± 1191 ± 21
Heart rate (beats/min)Survivors93 ± 1894 ± 2193 ± 2096 ± 15
Nonsurvivors96 ± 10107 ± 13111 ± 8113 ± 17
Diuresis (ml)Survivors1285 ± 11551424 ± 8611844 ± 11172015 ± 687
Nonsurvivors675 ± 389830 ± 563974 ± 4071257 ± 669
PaO2/FiO2 (mmHg)Survivors331 ± 121-325 ± 151356 ± 295
Nonsurvivors241 ± 133-266 ± 78235 ± 96

Data presented as mean ± standard deviation. PaO2/FiO2, partial pressure of arterial oxygen/inspired fraction of oxygen ratio.

Nine patients (seven nonsurvivors) developed complications such as severe sepsis, respiratory failure, abdominal fistula, and surgical wound infection. Figure 2 represents the receiver operating characteristics curves for initial values of blood lactate and SAPS II. The area under the curve was larger for SAPS II and for blood lactate, both for predicting complications or death, than the other variables (Table 3).
Figure 2

Receiver operating curves for Simplified Acute Physiology Score II (▲) and for lactate concentrations (■).

Table 3

Receiver operating characteristics curves at admission to the study

VariableArea mortalityArea complications
Simplified Acute Physiology Score II0.7050.678
Blood lactate (mEq/l)0.5830.646
Arterial bicarbonate (mEq/l)0.4520.375
Mean arterial pressure (mmHg)0.3250.377
PaO2/FiO2(mmHg)0.2350.249
Urine output (ml)0.3730.422
Heart rate (beats/min)0.5600.573

PaO2/FiO2, partial pressure of arterial oxygen/inspired fraction of oxygen ratio.

Discussion

The search for the optimal marker of adequate resuscitation continues. Intensivists agreed that traditional markers, such as blood pressure or urine output, are not sufficient indicators of adequate global perfusion. It is important to find a reliable indicator of perfusion since most deaths in the ICU are secondary to multiple organ failure, an end product of persistent hypoperfusion [20]. The optimal marker of adequate resuscitation would possess a number of desirable qualities: accuracy, ease and rapidity of acquisition, reproducibility in a broad variety of clinical hypoperfusion states, consistent results among different providers, and rapidity of change in response to change in clinical condition or to resuscitation. The study is a prospective examination of blood lactate as one of the more widely used markers of hypoperfusion. Lactate is a byproduct of anaerobic metabolism, elevated in hypoperfusion states when pyruvate cannot enter the Krebs cycle due to insufficient oxygen supply and it is shunted to lactate. In states of global hypoperfusion, lactate production exceeds its rate of metabolism and the blood lactate levels rise. Elevated blood lactate has been correlated strongly with mortality in many types of shock [4,6-11,21,22]. The rapidity at which lactate is cleared from the blood during resuscitation better correlates with outcome, including mortality or organ failure, than a single measurement of lactate [6,11-14]. Other markers of metabolic acidosis, such as base deficit or bicarbonate, have been used to evaluate resuscitation after trauma or septic shock [4,13,23,24]. In these studies, blood lactate levels were also elevated. Serum lactate and base deficit do not appear to be always linked. Abnormalities in the acid–base environment from the administered base, alterations in the body's buffer base, renal dysfunction, and electrolyte abnormalities have all been postulated as causes of this observed uncoupling. It seems this is the case for base deficit or bicarbonate in several studies studying different populations of critically ill patients in a context of a completed clinically global resuscitation. In contrast, there is consistent evidence that significant hyperlactatemia and dangerous hypoperfusion can exist despite lack of acidosis [6,8-10,25]. In addition, the use of lactate as an endpoint of resuscitation is based on a substantial body of literature, including multiple prospective studies in trauma patients, in surgical patients, in septic patients, and in mixed populations of critically ill patients [8,13,18,26]. Our hypothesis states that patients without signs of clinical shock can still be hypoperfused and are at risk for complications. We therefore studied high-risk surgical patients that have had a stable hemodynamic course during surgery and immediately after admission to the ICU. The results of this study indicate that the lactate level is superior to several clinical markers of shock or organ failure, including the heart rate, diuresis and the mean arterial pressure, or indices of metabolic acidosis. Lactate levels at admission (P = not significant) and after 12 hours (P = 0.012) separated survivors and nonsurvivors. In addition, persistent hyperlactetemia showed by the nonsurvivors at 48 hours correlates with a poor clinical outcome in accordance with previous observations. These data probably reflect a continuous and insufficient resuscitation. However, 29 survivors were discharged and one patient died before 48 hours, reducing the possibility to find statistically significant differences after 48 hours. We found that both lactate and bicarbonate showed a similar course for survivors and for nonsurvivors with time. The receiver operating characteristics curves, however, showed that lactate was significantly superior to any metabolic or hemodynamic variable and was comparable with SAPS II as a predictor of mortality or morbidity at admission to the ICU. Similar to our previous results in septic patients, or other studies in trauma, the lactate level of surgical or burn patients was found to be a significant predictor of mortality, while base deficit or bicarbonate failed to achieve clinical significance [6,8-10,25]. Blood lactate levels, particularly when hemodynamic alterations are taken into consideration, seem to have a similar value in identifying survivors when compared with more sophisticated scores like SAPS II or Acute Physiology and Chronic Health Evaluation II. In addition, and at the bedside, lactate values may give better relevant clinical information of what is occurring with the patient over time. Blood lactate concentrations are easily obtained and measured when compared with other monitoring variables, even before any invasive monitoring is available. Nevertheless, determinations of lactate concentrations have their limitations, especially in septic conditions when metabolic conditions can be complex (increased aerobic production, altered clearance in the liver and other organs, washout of accumulated lactate in the tissues, extracorporeal renal support with hemofiltration) [27-33]. Few patients in our study were septic or had liver dysfunction at admission to the study. None were actively resuscitated during the surgery and immediately after, and, finally, no patient was under extracorporeal renal support. Lung lactate production is significantly elevated in acute lung injury, particularly in septic conditions [34,35]. The nonsurvivors had a lower (P = not significant) PaO2/FiO2 ratio than the survivors. We did not measure the lactate gradient across the lung to verify whether the nonsurvivors had an increased lactate production by the lungs. However, no correlation was found between lactate levels and the PaO2/FiO2 ratio, and all patients, including the nonsurvivors, had no evidence of diffuse lung inflammatory processes during the first 48 hours. It is thus probable that hyperlactatemia of our patients was mainly due to hypoperfusion. This prospective study supports blood lactate levels as a marker of occult hypoperfusion. Blood lactate is reliable in predicting lethality in the early phase after high-risk surgery. Nonetheless, further studies are needed to demonstrate whether the identification and correction of hyperlactatemia may be beneficial in reducing morbidity and mortality in the stable surgical patient.

Competing interests

None declared.

Key messages

• Survival rates in high-risk surgical patients are associated with an adequate resuscitation • Adequate resuscitation cannot be based only on normalization of vital signs • Elevated blood lactate levels despite normal vital signs (occult hypoperfusion) are good markers of mortality in surgical patients • Resolution of persistent occult hypoperfusion may improve mortality rates in surgical patients

Abbreviations

ICU = intensive care unit; NS = not significant; PaO2/FiO2 = partial pressure of arterial oxygen/inspired fraction of oxygen ratio; SAPS II = Simplified Acute Physiology Score II.
  34 in total

1.  Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Authors:  E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Prolonged lactate clearance is associated with increased mortality in the surgical intensive care unit.

Authors:  J McNelis; C P Marini; A Jurkiewicz; S Szomstein; H H Simms; G Ritter; I M Nathan
Journal:  Am J Surg       Date:  2001-11       Impact factor: 2.565

3.  Appearance of excess lactate in anesthetized dogs during anemic and hypoxic hypoxia.

Authors:  S M Cain
Journal:  Am J Physiol       Date:  1965-09

4.  Lactate elimination in man: effects of lactate concentration and hepatic dysfunction.

Authors:  P J Woll; C O Record
Journal:  Eur J Clin Invest       Date:  1979-10       Impact factor: 4.686

5.  Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver.

Authors:  T C Vary; J H Siegel; T Nakatani; T Sato; H Aoyama
Journal:  Am J Physiol       Date:  1986-06

6.  Serum lactate and base deficit as predictors of mortality and morbidity.

Authors:  Farah A Husain; Matthew J Martin; Philip S Mullenix; Scott R Steele; David C Elliott
Journal:  Am J Surg       Date:  2003-05       Impact factor: 2.565

7.  Adrenergic blockade does not abolish elevated glucose turnover during bacterial infection.

Authors:  D M Hargrove; G J Bagby; C H Lang; J J Spitzer
Journal:  Am J Physiol       Date:  1988-01

8.  Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock).

Authors:  M H Weil; A A Afifi
Journal:  Circulation       Date:  1970-06       Impact factor: 29.690

9.  Relation of arterial blood lactate to oxygen delivery and hemodynamic variables in human shock states.

Authors:  A B Groeneveld; A D Kester; J J Nauta; L G Thijs
Journal:  Circ Shock       Date:  1987

10.  Pathological supply dependence of O2 uptake during bacteremia in dogs.

Authors:  D P Nelson; C Beyer; R W Samsel; L D Wood; P T Schumacker
Journal:  J Appl Physiol (1985)       Date:  1987-10
View more
  67 in total

1.  The effects of advanced monitoring on hemodynamic management in critically ill patients: a pre and post questionnaire study.

Authors:  Azriel Perel; Bernd Saugel; Jean-Louis Teboul; Manu L N G Malbrain; Francisco Javier Belda; Enrique Fernández-Mondéjar; Mikhail Kirov; Julia Wendon; Roger Lussmann; Marco Maggiorini
Journal:  J Clin Monit Comput       Date:  2015-12-10       Impact factor: 2.502

2.  Fluid administration for acute circulatory dysfunction using basic monitoring: narrative review and expert panel recommendations from an ESICM task force.

Authors:  Maurizio Cecconi; Glenn Hernandez; Martin Dunser; Massimo Antonelli; Tim Baker; Jan Bakker; Jacques Duranteau; Sharon Einav; A B Johan Groeneveld; Tim Harris; Sameer Jog; Flavia R Machado; Mervyn Mer; M Ignacio Monge García; Sheila Nainan Myatra; Anders Perner; Jean-Louis Teboul; Jean-Louis Vincent; Daniel De Backer
Journal:  Intensive Care Med       Date:  2018-11-19       Impact factor: 17.440

3.  Research in Latin America: opportunities and challenges.

Authors:  Elisa Estenssoro; Gilberto Friedman; Glenn Hernández
Journal:  Intensive Care Med       Date:  2016-04-04       Impact factor: 17.440

4.  A Computerized Alert Screening for Severe Sepsis in Emergency Department Patients Increases Lactate Testing but does not Improve Inpatient Mortality.

Authors:  T Berger; A Birnbaum; P Bijur; G Kuperman; P Gennis
Journal:  Appl Clin Inform       Date:  2010-11-17       Impact factor: 2.342

5.  Intraoperative fluid optimization using stroke volume variation in high risk surgical patients: results of prospective randomized study.

Authors:  Jan Benes; Ivan Chytra; Pavel Altmann; Marek Hluchy; Eduard Kasal; Roman Svitak; Richard Pradl; Martin Stepan
Journal:  Crit Care       Date:  2010-06-16       Impact factor: 9.097

Review 6.  Clinical significance of lactate in acute cardiac patients.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Gian Franco Gensini
Journal:  World J Cardiol       Date:  2015-08-26

7.  An evaluation of serial blood lactate measurement as an early predictor of shock and its outcome in patients of trauma or sepsis.

Authors:  Uma Krishna; Suresh P Joshi; Mukesh Modh
Journal:  Indian J Crit Care Med       Date:  2009 Apr-Jun

8.  Epidemiology of severe sepsis in the emergency department and difficulties in the initial assistance.

Authors:  Ederlon Rezende; João Manoel Silva; Alexandre Marine Isola; Edvaldo Vieira Campos; Cristina Prata Amendola; Samantha Longhi Almeida
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365

9.  The prognostic value of blood lactate levels relative to that of vital signs in the pre-hospital setting: a pilot study.

Authors:  Tim C Jansen; Jasper van Bommel; Paul G Mulder; Johannes H Rommes; Selma J M Schieveld; Jan Bakker
Journal:  Crit Care       Date:  2008-12-17       Impact factor: 9.097

10.  Occurrence and adverse effect on outcome of hyperlactatemia in the critically ill.

Authors:  Houman Khosravani; Reza Shahpori; H Thomas Stelfox; Andrew W Kirkpatrick; Kevin B Laupland
Journal:  Crit Care       Date:  2009-06-12       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.